This content is machine translated Heart damage Myocardial regeneration: feasible or wishful thinking? Regeneration of the heart is considered the “holy grail” of cardiology. Despite therapeutic advances with cholesterol-lowering drugs, beta-blockers, antihypertensives and other agents, heart failure caused by the loss or dysfunction…
View Post 7 min This content is machine translated Anticoagulation for atrial fibrillation New ESC guideline has adapted recommendations Atrial fibrillation is the most common persistent cardiac arrhythmia in adults. In the new guidelines for the management of atrial fibrillation, the European Society of Cardiology (ESC) pays particular attention…
View Post 4 min This content is machine translated Type 2 diabetes, high blood pressure and cardiovascular risk SGLT2 inhibitors are also a matter of the heart There are up to six SGLT isoforms, whereby SGLT2 has come into particular focus in recent years due to its importance for type 2 diabetes mellitus. SGLT2 inhibitors lower blood…
View Post 4 min This content is machine translated Cardiovascular primary prevention Do not use aspirin indiscriminately The benefits of acetylsalicylic acid (ASA) in the secondary prevention of atherosclerotic cardiovascular disease are considered proven. In primary prevention, however, the evidence is controversial. The current tenor is: routine…
View Post 12 min This content is machine translated Compression Lymphoedema and chronic wounds Lymphoedema is a chronic inflammatory disease of the interstitium as a result of primary (congenital) or secondary (acquired) damage to the lymphatic drainage system, which is characterized by inflammation, increased… CME-Test
View Post 4 min This content is machine translated Rare diseases Cogan syndrome – a clinical challenge The disease was first described in 1945 by the US physician David Glendering Cogan. The physician noticed a clear hearing loss in combination with keratitis. The exact causes are unclear,…
View Post 5 min This content is machine translated Stroke With polypills and co. against stroke and its consequences This year marked the tenth edition of the European Stroke Organization. Since the first conference, it has provided a platform for the presentation of studies that have changed clinical practice.…
View Post 5 min This content is machine translated Type 2 diabetes: reduction of microvascular and macrovascular risks The extensive toolbox has a lot to offer The fact that most type 2 diabetics today aim for an HbA1c value of <7% is partly due to the results of the UKPDS. This landmark study showed that the…
View Post 5 min This content is machine translated Metabolic Dysfunction-Associated Steatotic Liver Disease Cardiology and hepatology in one boat Metabolic dysfunction has far-reaching negative effects on the body, which can manifest as cardiovascular and liver disease. Traditionally, these conditions have been treated in an organ-centered manner, resulting in isolated…
View Post 5 min This content is machine translated Interventional cardiology Advances in AI-driven technologies A recently published review comprehensively discusses the impact of artificial intelligence (AI) on clinical practice in interventional cardiology (IC), with a focus on recent advances.
View Post 5 min This content is machine translated Hypertrophic cardiomyopathy Progress in gene therapy and future prospects Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy worldwide, affecting around 1 in 500 people. Current therapeutic interventions include lifestyle optimization, medications, septal reduction therapies and, rarely, heart transplantation.…
